ArticlePharmaceuticals (Basel, Switzerland)2022

Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats.

Vasudevan Mani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.